Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2013 May 1;6(8):877–885. doi: 10.1016/j.jcmg.2012.11.017

Figure 3.

Figure 3

Time dependent changes in quality of life (QOL) assessed by the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The total point mean ± the standard error are shown. There was a significant increase in the total score, indicating a negative impact on QOL, from baseline to 1 month after administration of low to moderate doses of anthracycline-based chemotherapy that was maintained through 6 months.

HHS Vulnerability Disclosure